$EVFM

$0.01 +$0.00 (2.67%) Close

$EVFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$EVFM Management Team

Ms. Saundra Pelletier

Interim Chairman of the Board of Directors

President

Chief Executive Officer

Age 55

Compensation $1.178M USD

Sex Female

Ms. Amy Raskopf

Chief Business Development Officer

Age -

Compensation -

Sex Female

Ms. Ivy Zhang

Chief Financial Officer

Secretary

Age 47

Compensation $695.3K USD

Sex Female

Name / Title	Age	Compensation	Sex
Ms. Saundra Pelletier Interim Chairman of the Board of Directors President Chief Executive Officer	55	$1.178M USD	Female
Ms. Amy Raskopf Chief Business Development Officer	-	-	Female
Ms. Ivy Zhang Chief Financial Officer Secretary	47	$695.3K USD	Female

Board of Directors

From the proxy statement filed Oct 29, 2025

Directors

serving now

Independent

4 of 4

stated in the proxy; 1 not stated

Average tenure

9.6 years

from year joined

CEO also chairs the board

Yes

Saundra Pelletier

Director	Age	On board	Independent	Committees	Other public boards	Pay
Kim Kamdar	58	2011 14 years	Independent	Nominating and Corporate Governance · Chair	Seraphina Therapeutics, Inc., Truvian Sciences	Not stated
Lisa Rarick	65	2020 5 years	Independent	Nominating and Corporate Governance	None stated	Not stated
Colin Rutherford	66	2015 10 years	Independent	Audit · Chair	New River REIT, PLC	Not stated
Tony O’Brien Lead independent director	62	2018 7 years	Independent	Audit Compensation · Chair	None stated	Not stated
Saundra Pelletier Board chair, CEO	56	2013 12 years	Not stated	None stated	Windtree Therapeutics, Inc., IMAC Holdings, Inc.	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Oct 29, 2025

Aditxt, Inc.

counterparty to the April and June securities purchase agreements

$2.3 million

2025

Sale of senior subordinated convertible notes and warrants to Aditxt in April 2025 (April Offering)

Open in proxy

Aditxt, Inc.

counterparty to the April and June securities purchase agreements

$1.4 million

2025

Sale of senior subordinated convertible notes and warrants to Aditxt in June 2025 (June Offering)

Open in proxy

Aditxt, Inc.

counterparty to the April and June securities purchase agreements

$4.0 million

2024

Issuance of Series F-1 Shares to Aditxt for cash during 2024

Open in proxy

Comments

Company Executives

$EVFM Management Team

Ms. Saundra Pelletier

Ms. Amy Raskopf

Ms. Ivy Zhang

Board of Directors

Related-party transactions